Fractionated follow-up chemotherapy delays the onset of resistance in bone metastatic prostate cancer
P. Warman, A. Kaznatcheev, A. Araujo, C. Lynch, D. Basanta
This paper introduces a model showing that fractionated follow-up chemotherapy delays resistance onset in bone metastatic prostate cancer compared to continuous or periodic schedules.
bioRxiv · Mar 2, 2018Cancer Biology